ArticleThrombosis journal2024

Correlation between a 2-week change in platelet count and clinical outcomes after the initiation of ravulizumab treatment in adult patients with atypical hemolytic uremic syndrome: post-hoc analysis of the phase III trial.

Masanori Matsumoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.